A Study of PRT-201 Administered Immediately After Radiocephalic Arteriovenous Fistula(AVF) Creation in Patients With Chronic Kidney Disease (CKD) (PATENCY-1)
NCT02110901
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
349
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
DRUG:
PRT-201
DRUG:
Placebo
Sponsor
Proteon Therapeutics